Arcellx Details Executive Compensation & Change-in-Control Payouts Amidst Gilead Acquisition

summarizeSummary

Arcellx filed an amended 10-K to disclose detailed executive compensation, including 150% bonus payouts for 2025, full equity acceleration upon the Gilead acquisition, and potential $25M tax gross-up payments for executives.

check_boxKey Events

• Executive Compensation Details Disclosed

  The 10-K/A includes comprehensive executive compensation for 2025, with CEO Rami Elghandour receiving $18.18 million, CFO Michelle Gilson $7.04 million, and CMO Christopher Heery $4.77 million.

• 150% Achievement of 2025 Annual Bonus Plan

  Named executive officers received 150% of their target annual bonuses for 2025, reflecting the company's strong performance against budgetary, manufacturing, clinical, commercial, and research goals.

• Full Equity Acceleration Upon Acquisition

  All outstanding equity awards held by named executive officers, other employees, and directors will fully vest immediately prior to the consummation of the acquisition by Gilead Sciences.

• Potential $25M Tax Gross-Up Payments

  Arcellx may pay up to an aggregate of $25 million, including gross-up payments, to employees and executive officers to cover Section 4999 excise taxes resulting from parachute payments related to the merger.

auto_awesomeAnalysis

This 10-K/A filing provides crucial details regarding executive compensation and the financial implications of the pending acquisition by Gilead Sciences, information previously omitted from the original 10-K. The disclosure highlights significant payouts for named executive officers, including 150% achievement of 2025 annual bonuses, reflecting strong operational performance leading up to the acquisition. Critically, all outstanding equity awards for executives and directors will fully accelerate upon the closing of the merger. Furthermore, the company may pay up to $25 million in gross-up payments to employees, including executives, to cover Section 4999 excise taxes related to parachute payments. These details are highly material for investors to understand the full financial impact of the acquisition on key personnel, especially as the stock trades near its 52-week high, aligning closely with the acquisition price.